Business Relations Table

Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

BR-Relations: 49

From Domain	Role	To Domain	Path
lskbiopharma.com	>>isReferenceFrom	elevartx.com	/2018/06/19/lskb-announces-that-enrollment-has-opened-at-huntsman-cancer-institute-for-the-appease-study-combining-rivoceranib-and-pembrolizumab/
healthcare.utah.edu	>>isReferenceFrom	elevartx.com	/2018/06/19/lskb-announces-that-enrollment-has-opened-at-huntsman-cancer-institute-for-the-appease-study-combining-rivoceranib-and-pembrolizumab/
eng.amc.seoul.kr	>>isReferenceFrom	elevartx.com	/2018/10/01/lskb-announces-mfds-approval-to-initiate-a-phase-i-iia-combination-study-of-rivoceranib-and-paclitaxel-at-asan-medical-center-south-korea/
oncologypro.esmo.org	>>isReferenceFrom	elevartx.com	/2019/09/29/elevar-announces-results-from-the-angel-trial-a-study-of-monotherapy-rivoceranib-apatinib-in-late-stage-gastric-cancer-patients/
c212.net	>>isReferenceFrom	elevartx.com	/2021/05/18/elevar-therapeutics-announce-new-data-highlighting-patient-burden-and-unmet-needs-associated-with-cremophor-based-cancer-treatments/
nam10.safelinks.protection.outlook.com	>>isReferenceFrom	elevartx.com	/2021/07/20/elevar-therapeutics-announces-ceo-transition-and-new-board-appointment/
hlbkorea.com	>>isReferenceFrom	elevartx.com	/2022/03/14/elevar-therapeutics-announces-key-management-changes/
clinicaltrialsarena.com	>>isReferenceFrom	elevartx.com	/2022/06/07/elevar-reports-positive-phase-ii-data-of-adenoid-cystic-carcinoma-therapy/
live-elevartherapeutics.pantheonsite.io	>>isReferenceFrom	elevartx.com	/2023/04/18/elevar-therapeutics-presents-aacr-2023-poster-demonstrating-rivoceranib-as-most-selective-vegfr-2-inhibitor-when-compared-to-other-tkis-with-known-activity-against-vegfr-2/
lifescievents.com	>>isReferenceFrom	elevartx.com	/2023/08/03/elevar-therapeutics-to-host-august-10-virtual-kol-event-on-phase-3-study-of-rivoceranib-in-combination-with-camrelizumab-in-unresectable-hepatocellular-carcinoma-uhcc/
bluefaery.org	>>isReferenceFrom	elevartx.com	/2023/09/19/elevar-therapeutics-joins-benefactors-council-of-blue-faery-leading-hepatocellular-carcinoma-advocacy-group/
cancer.net	>>isReferenceFrom	elevartx.com	/2023/10/17/elevar-therapeutics-and-jiangsu-hengrui-pharma-announce-global-commercialization-licensing-agreement-for-pd-1-inhibitor-camrelizumab-in-combination-with-rivoceranib-for-uhcc/
ema.europa.eu	>>isReferenceFrom	elevartx.com	/2024/08/01/elevar-therapeutics-granted-orphan-designation/
cslide.ctimeetingtech.com	>>isReferenceFrom	elevartx.com	/2024/09/12/elevar-therapeutics-reports-advances-in-hcc-at-esmo/
cancer.org	>>isReferenceFrom	elevartx.com	/2024/10/21/elevar-therapeutics-fda-acceptance-of-new-drug-resubmission-2/
ascopubs.org	>>isReferenceFrom	elevartx.com	/2025/01/24/elevar-therapeutics_post-hoc_analysis_cares-310_impact_of_viral_vs_non-viral_etiology/
meetings.asco.org	>>isReferenceFrom	elevartx.com	/2025/01/24/elevar-therapeutics_post-hoc_analysis_cares-310_impact_of_viral_vs_non-viral_etiology/
thelancet.com	>>isReferenceFrom	elevartx.com	/2026/02/02/elevar-fda-acceptance-rivo/
WWW.X.COM	>>isReferenceFrom	elevartx.com	/2026/06/22/elevar-first-patient-dosed-lira/
globenewswire.com	>>isReferenceFrom	elevartx.com	/2026/07/10/elevar-crl-july-2/

1 2 3 Nächste

Business Relations Table - o4.fyi ()

BR-Editor

Domain-Statistiken für "elevartx.com"

BR-Relations: 49